Biological horizons for targeting brain malignancy

Advances in Experimental Medicine and Biology

Volumn 671, Issue , 2010, Pages 93-104

  Hughes, Samuel A ^b   Achanta, Pragathi ^b   Ho, Allen L ^b   Duenas, Vincent J ^b   Quinones Hinojosa, Alfredo ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOSINE DEAMINASE; DEOXYCYTIDINE KINASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOSHELL; SITIMAGENE CERADENOVEC; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; BRAIN CANCER; CANCER STEM CELL; CELL HOMING; CELL REGENERATION; CELL RENEWAL; EMBRYONIC STEM CELL; GENE DIRECTED ENZYME PRODRUG THERAPY; HUMAN; NEURAL STEM CELL; NEUROSURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM; BRAIN TUMOR; DRUG DELIVERY SYSTEM; GENE THERAPY; GLIOMA; METHODOLOGY; NERVE CELL; PATHOLOGY; PHYSIOLOGY; STEM CELL; STEM CELL TRANSPLANTATION;

BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; GENE THERAPY; GLIOMA; NEURONS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 77952995764     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5819-8_8     Document Type: Article

References (139)

1. Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352(10):987-96. (Pubitemid 40349501)
2. CBTRUS. CBTRUS Primary Brain Tumors in the United States. Central Brain Tumor Registry of the United States; 2005-2006.
3. Louis DN, Ohgaki H, Wiestler OD et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 2007; 114(2):97-109. (Pubitemid 47103521)
4. Laws ER, Parney IF, Huang W et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: Data from the Glioma Outcomes Project. J Neurosurg 2003; 99(3):467-73. (Pubitemid 37040405)
5. Chang SM, Parney IF, Huang W et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA 2005; 293(5):557-64. (Pubitemid 40171237)
6. DeAngelis LM. Brain tumors. N Engl J Med 2001; 344(2):114-23. (Pubitemid 32052502)
7. McGirt MJ, Chaichana KL, Attenello FJ et al. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008; 63(4):700-7; author reply 7-8.
8. Altman J, Das GD. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 1965; 124(3):319-35.
9. Altman J, Das GD. Autoradiographic and histological studies of postnatal neurogenesis. I. A longitudinal investigation of the kinetics, migration and transformation of cells incorporating tritiated thymidine in neonate rats, with special reference to postnatal neurogenesis in some brain regions. J Comp Neurol 1966; 126(3):337-89.
10. Gage FH, Kempermann G, Palmer TD et al. Multipotent progenitor cells in the adult dentate gyrus.J Neurobiol 1998; 36(2):249-66. (Pubitemid 28363235)
11. Quinones-Hinojosa A, Chaichana K. The human subventricular zone: A source of new cells and a potential source of brain tumors. Exp Neurol 2007; 205(2):313-24. (Pubitemid 46755774)
12. Quinones-Hinojosa A, Sanai N, Soriano-Navarro M et al. Cellular composition and cytoarchitecture of the adult human subventricular zone: A niche of neural stem cells. J Comp Neurol 2006; 494(3):415-34. (Pubitemid 41794059)
13. Aboody KS, Brown A, Rainov NG et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97(23):12846-51.
14. Hemmati HD, Nakano I, Lazareff JA et al. Cancerous stem cells can arise from pediatric brain tumors.Proc Natl Acad Sci USA 2003; 100(25):15178-83. (Pubitemid 37518036)
15. Galli R, Binda E, Orfanelli U et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64(19):7011-21. (Pubitemid 39331011)
16. Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors.Cancer Res 2003; 63(18):5821-8. (Pubitemid 37187480)
17. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004; 432(7015):396-401. (Pubitemid 39551674)
18. Yuan X, Curtin J, Xiong Y et al. Isolation of cancer stem cells from adult glioblastoma multiforme.Oncogene 2004; 23(58):9392-400. (Pubitemid 40069671)
19. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin of gliomas. N Engl J Med 2005; 353(8):811-22.
20. Bachoo RM, Maher EA, Ligon KL et al. Epidermal growth factor receptor and Ink4?/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002; 1(3):269-77. (Pubitemid 41039151)
21. Clarke MF. Neurobiology: At the root of brain cancer. Nature 2004; 432(7015):281-2.
22. Berger F, Gay E, Pelletier L et al. Development of gliomas: Potential role of asymmetrical cell division of neural stem cells. Lancet Oncol 2004; 5(8):511-4. (Pubitemid 39069402)
23. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002; 2(8):616-26. (Pubitemid 37328928)
24. Romer JT, Kimura H, Magdaleno S et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(+/-) mice. Cancer Cell 2004; 6(3):229-40. (Pubitemid 39222036)
25. Nelson SJ, Cha S. Imaging glioblastoma multiforme. Cancer J 2003; 9(2):134-45.
26. Benedetti S, Bruzzone MG, Pollo B et al. Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene. Cancer Res 1999; 59(3):645-52. (Pubitemid 29076063)
27. Ehtesham M, Kabos P, Kabosova A et al. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002; 62(20):5657-63. (Pubitemid 35204717)
28. Laywell ED, Steindler DA, Silver DJ. Astrocytic stem cells in the adult brain. Neurosurg Clin N Am 2007; 18(1):21-30, viii. (Pubitemid 46161191)
29. Campbell K, Olsson M, Bjorklund A. Regional incorporation and site-specific differentiation of striatal precursors transplanted to the embryonic forebrain ventricle. Neuron 1995; 15(6):1259-73. (Pubitemid 26005365)
30. Sidman RL, Miale IL, Feder N. Cell proliferation and migration in the primitive ependymal zone: An autoradiographic study of histogenesis in the nervous system. Exp Neurol 1959; 1:322-33.
31. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992; 255(5052):1707-10.
32. Reynolds BA, Tetzlaff W, Weiss S. A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J Neurosci 1992; 12(11):4565-74.
33. Reubinoff BE, Pera MF, Vajta G et al. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 2001; 16(10):2187-94. (Pubitemid 32951916)
34. Zhang ZG, Jiang Q, Zhang R et al. Magnetic resonance imaging and neurosphere therapy of stroke in rat. Ann Neurol 2003; 53(2):259-63. (Pubitemid 36164010)
35. Snyder EY, Deitcher DL, Walsh C et al. Multipotent neural cell lines can engraft and participate in development of mouse cerebellum. Cell 1992; 68(1):33-51.
36. Palmer TD, Schwartz PH, Taupin P et al. Cell culture. Progenitor cells from human brain after death.Nature 2001; 411(6833):42-3. (Pubitemid 32428181)
37. Rosario CM, Yandava BD, Kosaras B et al. Differentiation of engrafted multipotent neural progenitors towards replacement of missing granule neurons in meander tail cerebellum may help determine the locus of mutant gene action. Development 1997; 124(21):4213-24. (Pubitemid 27496857)
38. Snyder EY, Yoon C, Flax JD et al. Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proc Natl Acad Sci USA 1997; 94(21):11663-8. (Pubitemid 27451055)
39. Zlomanczuk P, Mrugala M, de la Iglesia HO et al. Transplanted clonal neural stem-like cells respond to remote photic stimulation following incorporation within the suprachiasmatic nucleus. Exp Neurol 2002; 174(2):162-8. (Pubitemid 34293446)
40. Park KI, Liu S, Flax JD et al. Transplantation of neural progenitor and stem cells: Developmental insights may suggest new therapies for spinal cord and other CNS dysfunction. J Neurotrauma 1999; 16(8):675-87. (Pubitemid 29422792)
41. Flax JD, Aurora S, Yang C et al. Engraftable human neural stem cells respond to developmental cues, replace neurons and express foreign genes. Nat Biotechnol 1998; 16(11):1033-9. (Pubitemid 28515895)
42. Yip S, Sabetrasekh R, Sidman RL et al. Neural stem cells as novel cancer therapeutic vehicles. Eur J Cancer 2006; 42(9):1298-308. (Pubitemid 44208865)
43. Snyder EY, Loring JF. A role for stem cell biology in the physiological and pathological aspects of aging.J Am Geriatr Soc 2005; 53(9 Suppl):S287-91. (Pubitemid 41783137)
44. Kosztowski T, Zaidi HA, Quinones-Hinojosa A. Applications of neural and mesenchymal stem cells in the treatment of gliomas. Expert Rev Anticancer Ther 2009; 9(5):597-612.
45. Zaidi HA DMF, Quinones-Hinojosa A. Brain Tumor Stem Cells. In: Youman, ed. Textbook of Neurological Surgery. 6th ed, 2008.
46. Chaichana KL, McGirt MJ, Laterra J et al. Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg 2009.
47. Benedetti S, Pirola B, Pollo B et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000; 6(4):447-50. (Pubitemid 30208163)
48. Ehtesham M, Kabos P, Gutierrez MA et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002; 62(24):7170-4. (Pubitemid 36025232)
49. Barresi V, Belluardo N, Sipione S et al. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene Ther 2003; 10(5):396-402. (Pubitemid 36528783)
50. Uhl M, Weiler M, Wick W et al. Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. Biochem Biophys Res Commun 2005; 328(1):125-9. (Pubitemid 40164644)
51. Li S, Tokuyama T, Yamamoto J et al. Bystander effect-mediated gene therapy of gliomas using genetically engineered neural stem cells. Cancer Gene Ther 2005; 12(7):600-7. (Pubitemid 40967220)
52. Darsalia V, Heldmann U, Lindvall O et al. Stroke-induced neurogenesis in aged brain. Stroke 2005; 36(8):1790-5. (Pubitemid 41098780)
53. Liu YP, Lang BT, Baskaya MK et al. The potential of neural stem cells to repair stroke-induced brain damage. Acta Neuropathol 2009.
54. Snethen H, Love S, Scolding N. disease-responsive neural precursor cells are present in multiple sclerosis lesions. Regen Med 2008; 3(6):835-47.
55. Kendall SE, Najbauer J, Johnston HF et al. Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling. Stem Cells 2008; 26(6):1575-86.
56. Zhao D, Najbauer J, Garcia E et al. Neural stem cell tropism to glioma: Critical role of tumor hypoxia.Mol Cancer Res 2008; 6(12):1819-29.
57. Glass R, Synowitz M, Kronenberg G et al. Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J Neurosci 2005; 25(10):2637-46. (Pubitemid 40365175)
58. Fomchenko EI, Holland EC. Stem cells and brain cancer. Exp Cell Res 2005; 306(2):323-9. (Pubitemid 40732756)
59. Walzlein JH, Synowitz M, Engels B et al. The antitumorigenic response of neural precursors depends on subventricular proliferation and age. Stem Cells 2008; 26(11):2945-54.
60. Klassen H. Recruitment of endogenous neural progenitor cells by malignant neoplasms of the central nervous system. Curr Stem Cell Res Ther 2007; 2(2):113-9. (Pubitemid 46823011)
61. Doetsch F, Petreanu L, Caille I et al. EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron 2002; 36(6):1021-34. (Pubitemid 36044505)
62. Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000; 425(4):479-94.
63. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006; 6(6):425-36.
64. Lim DA, Cha S, Mayo MC et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol 2007; 9(4):424-9.
65. Mineo JF, Bordron A, Baroncini M et al. Prognosis factors of survival time in patients with glioblastoma multiforme: A multivariate analysis of 340 patients. Acta Neurochir (Wien) 2007; 149(3):245-53.
66. Chaichana KL, McGirt MJ, Frazier J et al. Relationship of glioblastoma multiforme to the lateral ventricles predicts survival following tumor resection. J Neurooncol 2008.
67. Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature 1995; 374(6520):367-70.
68. Yandava BD, Billinghurst LL, Snyder EY. "Global" cell replacement is feasible via neural stem cell transplantation: Evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci USA 1999; 96(12):7029-34. (Pubitemid 29275004)
69. Lacorazza HD, Flax JD, Snyder EY et al. Expression of human beta-hexosaminidase alpha-subunit gene (the gene defect of Tay-Sachs disease) in mouse brains upon engraftment of transduced progenitor cells.Nat Med 1996; 2(4):424-9. (Pubitemid 26191914)
70. Snyder EY, Park KI, Flax JD et al. Potential of neural "stem-like" cells for gene therapy and repair of the degenerating central nervous system. Adv Neurol 1997; 72:121-32.
71. Riess P, Zhang C, Saatman KE et al. Transplanted neural stem cells survive, differentiate and improve neurological motor function after experimental traumatic brain injury. Neurosurgery 2002; 51(4):1043-52; discussion 52-4.
72. Yip S, Aboody KS, Burns M et al. Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J 2003; 9(3):189-204.
73. Yip SS Rl, Snyder EY. Stem cells for targeting CNS malignancy. Principles of molecular neurosurgery: Basel: Karger Publishers, 2005;624-44.
74. Erlandsson A, Larsson J, Forsberg-Nilsson K. Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp Cell Res 2004; 301(2):201-10. (Pubitemid 39504973)
75. Widera D, Holtkamp W, Entschladen F et al. MCP-1 induces migration of adult neural stem cells. Eur J Cell Biol 2004; 83(8):381-7. (Pubitemid 39307175)
76. Sun L, Lee J, Fine HA. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J Clin Invest 2004; 113(9):1364-74. (Pubitemid 39069935)
77. Serfozo P, Schlarman MS, Pierret C et al. Selective migration of neuralized embryonic stem cells to stem cell factor and media conditioned by glioma cell lines. Cancer Cell Int 2006; 6:1.
78. Werbowetski T, Bjerkvig R, Del Maestro RF. Evidence for a secreted chemorepellent that directs glioma cell invasion. J Neurobiol 2004; 60(1):71-88. (Pubitemid 38765957)
79. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2(2):108-15. (Pubitemid 33707927)
80. Zagzag D, Esencay M, Mendez O et al. Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: One plausible explanation of Scherer's structures. Am J Pathol 2008; 173(2):545-60.
81. Itoh T, Satou T, Ishida H et al. The relationship between SDF-1alpha/CXCR4 and neural stem cells appearing in damaged area after traumatic brain injury in rats. Neurol Res 2009; 31(1):90-102.
82. Imitola J, Raddassi K, Park KI et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004; 101(52):18117-22. (Pubitemid 40054083)
83. Lazarini F, Tham TN, Casanova P et al. Role of the alpha-chemokine stromal cell-derived factor (SDF-1) in the developing and mature central nervous system. Glia 2003; 42(2):139-48. (Pubitemid 36565118)
84. Rempel SA, Dudas S, Ge S et al. Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 2000; 6(1):102-11. (Pubitemid 30064982)
85. Zhou Y, Larsen PH, Hao C et al. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 2002; 277(51):49481-7. (Pubitemid 36014384)
86. Rubin JB, Kung AL, Klein RS et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 2003; 100(23):13513-8. (Pubitemid 37444773)
87. Allport JR, Shinde Patil VR, Weissleder R. Murine neuronal progenitor cells are preferentially recruited to tumor vasculature via alpha4-integrin and SDF-1alpha-dependent mechanisms. Cancer Biol Ther 2004; 3(9):838-44. (Pubitemid 41351047)
88. Fears CY, Sontheimer HW, Bullard DC et al. Could labeled neuronal progenitor cells be used to target glioma tumor endothelium? Cancer Biol Ther 2004; 3(9):845-6. (Pubitemid 41351048)
89. Ehtesham M, Yuan X, Kabos P et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004; 6(3):287-93. (Pubitemid 38657085)
90. Tabatabai G, Bahr O, Mohle R et al. Lessons from the bone marrow: How malignant glioma cells attract adult haematopoietic progenitor cells. Brain 2005; 128(Pt 9):2200-11. (Pubitemid 41253286)
91. Pluchino S, Zanotti L, Rossi B et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 2005; 436(7048):266-71. (Pubitemid 41021278)
92. Lee BC, Lee TH, Avraham S et al. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2004; 2(6):327-38. (Pubitemid 39025295)
93. Liang Z, Wu T, Lou H et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004; 64(12):4302-8. (Pubitemid 38802437)
94. Schmidt NO, Przylecki W, Yang W et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 2005; 7(6):623-9. (Pubitemid 40967763)
95. Kaur B, Tan C, Brat DJ et al. Genetic and hypoxic regulation of angiogenesis in gliomas. J Neurooncol 2004; 70(2):229-43. (Pubitemid 39545734)
96. Lambrechts D, Carmeliet P. VEGF at the neurovascular interface: Therapeutic implications for motor neuron disease. Biochim Biophys Acta 2006; 1762(11-12):1109-21. (Pubitemid 44781175)
97. Cross MJ, Dixelius J, Matsumoto T et al. VEGF-receptor signal transduction. Trends Biochem Sci 2003; 28(9):488-94. (Pubitemid 38340413)
98. Zhang H, Vutskits L, Pepper MS et al. VEGF is a chemoattractant for FGF-2-stimulated neural progenitors.J Cell Biol 2003; 163(6):1375-84. (Pubitemid 38032097)
99. Schmidt NO, Koeder D, Messing M et al. Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche.Brain Res 2009.
100. Feldkamp MM, Lau N, Guha A. Signal transduction pathways and their relevance in human astrocytomas.J Neurooncol 1997; 35(3):223-48. (Pubitemid 27511128)
101. Dunn IF, Heese O, Black PM. Growth factors in glioma angiogenesis: FGFs, PDGF, EGF and TGFs.J Neurooncol 2000; 50(1-2):121-37. (Pubitemid 32169649)
102. Chicoine MR, Silbergeld DL. Mitogens as motogens. J Neurooncol 1997; 35(3):249-57. (Pubitemid 27511129)
103. Boockvar JA, Kapitonov D, Kapoor G et al. Constitutive EGFR signaling confers a motile phenotype to neural stem cells. Mol Cell Neurosci 2003; 24(4):1116-30. (Pubitemid 38091521)
104. Mellinghoff IK, Wang MY, Vivanco I et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 2005; 353(19):2012-24. (Pubitemid 41609094)
105. Lefranc F, Brotchi J, Kiss R. Possible future issues in the treatment of glioblastomas: Special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 2005; 23(10):2411-22. (Pubitemid 46218735)
106. Tatenhorst L, Puttmann S, Senner V et al. Genes associated with fast glioma cell migration in vitro and in vivo. Brain Pathol 2005; 15(1):46-54. (Pubitemid 40224066)
107. Ma HI, Lin SZ, Chiang YH et al. Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector. Gene Ther 2002; 9(1):2-11.
108. Gomez-Manzano C, Yung WK, Alemany R et al. Genetically modified adenoviruses against gliomas: From bench to bedside. Neurology 2004; 63(3):418-26. (Pubitemid 39031369)
109. Li S, Gao Y, Tokuyama T et al. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett 2007; 251(2):220-7. (Pubitemid 46669798)
110. Herrlinger U, Woiciechowski C, Sena-Esteves M et al. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther 2000; 1(4):347-57.
111. Eklund JW, Kuzel TM. A review of recent findings involving interleukin-2-based cancer therapy. Curr Opin Oncol 2004; 16(6):542-6. (Pubitemid 39482972)
112. Smyth MJ, Cretney E, Kershaw MH et al. Cytokines in cancer immunity and immunotherapy. Immunol Rev 2004; 202:275-93. (Pubitemid 39576919)
113. Jean WC, Spellman SR, Wallenfriedman MA et al. Interleukin-12-based immunotherapy against rat 9L glioma. Neurosurgery 1998; 42(4):850-6; discussion 6-7.
114. Ehtesham M, Samoto K, Kabos P et al. Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer. Cancer Gene Ther 2002; 9(11):925-34. (Pubitemid 35278565)
115. Rhines LD, Sampath P, DiMeco F et al. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: A novel treatment for experimental malignant glioma. Neurosurgery 2003; 52(4):872-9; discussion 9-80.
116. Yang SY, Liu H, Zhang JN. Gene therapy of rat malignant gliomas using neural stem cells expressing IL-12. DNA Cell Biol 2004; 23(6):381-9. (Pubitemid 38850385)
117. Kim SK, Cargioli TG, Machluf M et al. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 2005; 11(16):5965-70. (Pubitemid 41170327)
118. Zhang Z, Jiang Q, Jiang F et al. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 2004; 23(1):281-7. (Pubitemid 39119458)
119. Daldrup-Link HE, Rudelius M, Piontek G et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: In vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005; 234(1):197-205. (Pubitemid 39658386)
120. Stroh M, Zimmer JP, Duda DG et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat Med 2005; 11(6):678-82. (Pubitemid 40868310)
121. Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005; 65(8):3307-18. (Pubitemid 40524615)
122. Chiocca EA, Aghi M, Fulci G. Viral therapy for glioblastoma. Cancer J 2003; 9(3):167-79.
123. Chiocca EA, Broaddus WC, Gillies GT et al. Neurosurgical delivery of chemotherapeutics, targeted toxins, genetic viral therapies in neuro-oncology. J Neurooncol 2004; 69(1-3):101-17. (Pubitemid 39256123)
124. Kew Y, Levin VA. Advances in gene therapy and immunotherapy for brain tumors. Curr Opin Neurol 2003; 16(6):665-70. (Pubitemid 38429239)
125. Kurihara H, Zama A, Tamura M et al. Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator. Gene Ther 2000; 7(8):686-93. (Pubitemid 30255773)
126. Fueyo J, Alemany R, Gomez-Manzano C et al. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst 2003; 95(9):652-60. (Pubitemid 36603721)
127. Stojdl DF, Lichty BD, tenOever BR et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003; 4:263-75. (Pubitemid 37329791)
128. Manome Y, Wen PY, Dong Y et al. Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivo. Nat Med 1996; 2(5):567-73. (Pubitemid 26150684)
129. Lynch WP, Sharpe AH, Snyder EY. Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: Evidence from studying retroviral env-related neurodegeneration. J Virol 1999; 73(8):6841-51. (Pubitemid 29327867)
130. Arnhold S, Hilgers M, Lenartz D et al. Neural precursor cells as carriers for a gene therapeutical approach in tumor therapy. Cell Transplant 2003; 12(8):827-37.
131. Ehtesham M, Samoto K, Kabos P et al. Treatment of intracranial glioma with in situ interferon-gamma and necrosis factor-alpha gene transfer. Cancer Gene Ther 2002; 9(11):925-34. (Pubitemid 35278565)
132. Walczak H, Miller RE, Ariail K et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-ligand in vivo. Nat Med 1999; 5(2):157-63. (Pubitemid 29068521)
133. Kim I, Kim H, Im S et al. Induction of intracranial glioblastoma apoptosis by transplantation of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) expressing human neural stem cells (NSCs).In: Annual meeting of society of neuroscience. San Diego; 2004.
134. Lewin M, Carlesso N, Tung CH et al. Tat peptide-derivatized magnetic nanoparticles allow in recovery of progenitor cells. Nat Biotechnol 2000; 18(4):410-4. (Pubitemid 30217528)
135. Anderson SA, Glod J, Arbab AS et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005; 105(1):420-5. (Pubitemid 40053114)
136. Jaiswal JK, Simon SM. Potentials and pitfalls of fluorescent quantum dots for biological imaging. Trends Cell Biol 2004; 14(9):497-504. (Pubitemid 39209357)
137. Gao X, Cui Y, Levenson RM et al. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22(8):969-76. (Pubitemid 39014473)
138. Loo C, Lowery A, Halas N et al. Immunotargeted nanoshells for integrated cancer imaging and therapy.Nano Lett 2005; 5(4):709-11. (Pubitemid 40609745)
139. Hirsch LR, Stafford RJ, Bankson JA et al. Nanoshell-mediated near-infrared thermal therapy of tumors undermagnetic resonance guidance. Proc Natl Acad Sci USA 2003; 100(23):13549-54. (Pubitemid 37444779)